Monogram Orthopaedics Inc
NASDAQ:MGRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Monogram Orthopaedics Inc
Cash Equivalents
Monogram Orthopaedics Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Monogram Orthopaedics Inc
NASDAQ:MGRM
|
Cash Equivalents
$15.7m
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cadre Holdings Inc
NYSE:CDRE
|
Cash Equivalents
$122.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
|
|
Glaukos Corp
NYSE:GKOS
|
Cash Equivalents
$90.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$4B
|
CAGR 3-Years
30%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
UFP Technologies Inc
NASDAQ:UFPT
|
Cash Equivalents
$20.3m
|
CAGR 3-Years
65%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Alphatec Holdings Inc
NASDAQ:ATEC
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Monogram Orthopaedics Inc
Glance View
Monogram Orthopaedics Inc is a US-based company operating in industry. The company is headquartered in Brooklyn, New York. The company went IPO on 2023-05-18. Monogram Orthopaedics Inc. (Monogram) is engaged in developing a product solution architecture for mass personalization of orthopedic implants by linking three-dimensional (3D) printing and robotics via automated digital image analysis algorithms. Its primary business is to market orthopedic implants insertable with its orthopedic robot. The company has a navigated robot prototype that can optically track a simulated surgical target and execute optimized auto-generated cut paths for precision insertion of implants in synthetic bone specimens. These implants and cut paths are generated with Monogram software algorithms. The Monogram technology platform consists of a workflow to prepare a patient-specific surgical plan from a computed tomography scan. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
See Also
What is Monogram Orthopaedics Inc's Cash Equivalents?
Cash Equivalents
15.7m
USD
Based on the financial report for Dec 31, 2024, Monogram Orthopaedics Inc's Cash Equivalents amounts to 15.7m USD.
What is Monogram Orthopaedics Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
41%
Over the last year, the Cash Equivalents growth was 15%. The average annual Cash Equivalents growth rates for Monogram Orthopaedics Inc have been 41% over the past three years .
